CN Patent

CN102178694B — 磷酸钠盐液体制剂

Assigned to Sichuan Jewelland Pharmaceutical Co Ltd · Expires 2013-03-20 · 13y expired

What this patent protects

一种磷酸钠盐液体制剂，每1000ml所述液体制剂含有40～180g的Na 2 HPO 4 ·7H 2 O，100～480g的NaH 2 PO 4 ·H 2 O，0.05～0.3g的防腐剂。该磷酸钠盐液体制剂防腐效果好，磷酸钠盐采用Na 2 HPO 4 ·7H 2 O与NaH 2 PO 4 ·H 2 O的混合物，其溶解性好，溶解速度快，稳定性好。

USPTO Abstract

一种磷酸钠盐液体制剂，每1000ml所述液体制剂含有40～180g的Na 2 HPO 4 ·7H 2 O，100～480g的NaH 2 PO 4 ·H 2 O，0.05～0.3g的防腐剂。该磷酸钠盐液体制剂防腐效果好，磷酸钠盐采用Na 2 HPO 4 ·7H 2 O与NaH 2 PO 4 ·H 2 O的混合物，其溶解性好，溶解速度快，稳定性好。

Drugs covered by this patent

sodium-phosphate-dibasic-anhydrous (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS)

Patent Metadata

Patent number: CN102178694B
Jurisdiction: CN
Classification: —
Expires: 2013-03-20
Drug substance claim: No
Drug product claim: No
Assignee: Sichuan Jewelland Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.